Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
69
NBTX Quote, Financials, Valuation and Earnings
Last price:
$22.00
Seasonality move
:
-2.12%
Day range:
$20.05 - $21.03
52-week range:
$2.76 - $30.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
29.34x
P/B ratio:
--
Volume:
20.4K
Avg. volume:
84.3K
1-year change:
625.17%
Market cap:
$1B
Revenue:
-$12.6M
EPS (TTM):
-$0.80
Analysts' Opinion
-
Consensus RatingNanobiotix SA has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $14.74, Nanobiotix SA has an estimated downside of -29.78% from its current price of $21.03.
-
Price Target UpsideAccording to analysts, the highest upside price target is $25.96 representing -100% upside increase from its current price of $21.03.
Fair Value
-
According to the consensus of 5 analysts, Nanobiotix SA has -29.78% downside to fair value with a price target of $14.74 per share.
NBTX vs. S&P 500
-
Over the past 5 trading days, Nanobiotix SA has underperformed the S&P 500 by -0.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nanobiotix SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nanobiotix SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nanobiotix SA reported revenues of --.
Earnings Growth
-
Nanobiotix SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nanobiotix SA reported earnings per share of --.
Enterprise value:
351.4M
EV / Invested capital:
--
Price / LTM sales:
29.34x
EV / EBIT:
--
EV / Revenue:
3.79x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-16.11x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-44.94%
Net Income Margin (TTM):
-92.41%
Return On Equity:
--
Return On Invested Capital:
-161.14%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-05 | 2024-12-05 | 2024-12-05 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $137.9M | $76.1M | $36.5M | $86.2M | -- | |
| Total Assets | $147.5M | $84.2M | $43.9M | $92.9M | -- | |
| Current Liabilities | $45.3M | $44.5M | $54.2M | $60.6M | -- | |
| Total Liabilities | $98.2M | $82.3M | $102.4M | $116.3M | -- | |
| Total Equity | $49.3M | $1.9M | -$58.4M | -$23.3M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-05 | 2024-12-05 | 2024-12-05 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
NBTX
Sector
Market Cap
$1B
$28.4M
Price % of 52-Week High
69.29%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.32%
1-Year Price Total Return
625.17%
-22.19%
Beta (5-Year)
--
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$20.91
200-day SMA
Buy
Level
$9.29
Bollinger Bands (100)
Buy
Level
7.66 - 21.76
Chaikin Money Flow
Buy
Level
3.9M
20-day SMA
Buy
Level
$20.90
Relative Strength Index (RSI14)
Buy
Level
51.64
ADX Line
Buy
Level
11.46
Williams %R
Neutral
Level
-57.1914
50-day SMA
Sell
Level
$21.19
MACD (12, 26)
Buy
Level
0.17
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
49.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.2587)
Sell
CA Score
(Annual)
Level (-8.7569)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (13.4531)
Sell
Piotroski F Score
(Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Stock Forecast FAQ
In the current month, NBTX has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The NBTX average analyst price target in the past 3 months is $14.74.
-
Where Will Nanobiotix SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nanobiotix SA share price will drop to $14.74 per share over the next 12 months.
-
What Do Analysts Say About Nanobiotix SA?
Analysts are divided on their view about Nanobiotix SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nanobiotix SA is a Sell and believe this share price will rise from its current level to $3.83.
-
What Is Nanobiotix SA's Price Target?
The price target for Nanobiotix SA over the next 1-year time period is forecast to be $14.74 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is NBTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nanobiotix SA is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NBTX?
You can purchase shares of Nanobiotix SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nanobiotix SA shares.
-
What Is The Nanobiotix SA Share Price Today?
Nanobiotix SA was last trading at $22.00 per share. This represents the most recent stock quote for Nanobiotix SA. Yesterday, Nanobiotix SA closed at $21.03 per share.
-
How To Buy Nanobiotix SA Stock Online?
In order to purchase Nanobiotix SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NBTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NBTX
Sector
P/E ratio
--
23.66x
PEG ratio
--
-0.01x
P/B ratio
--
1.84x
Price / LTM sales
29.34x
1.60x
Growth Metrics
NBTX
Sector
Revenue growth
--
4.85%
Earnings growth
--
11.15%
Revenue (5-year growth)
198.65%
6.45%
Earnings forecast
--
-$0.20
Profitability
NBTX
Sector
Profitability FY 2024
--
$3.6M
Return on invested capital
-161.14%
-30.98%
Return on assets
-44.94%
-27.62%
Return on equity
--
-36.69%
Earnings Date
Last Earnings Date
Sep
30
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Dec
30
Balance Sheet
NBTX
Sector
Total cash
$71.1M
$27.2M
Short term investments
--
$25.7M
Total assets
$69.8M
$79.9M
Long term debt
$47.7M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
